![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Maprimed S.a. Buenos Aires Ar, based in Argentina, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Fingolimod hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2020-312 - Rev 01
This Chemical Type CEP, issued on July 10, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2988 associated with this CEP further emphasizes